<DOC>
	<DOCNO>NCT01835977</DOCNO>
	<brief_summary>Multi-centre Randomized Clinical Trial : 200 patient confirmed unilateral high-volume low risk ( Gleason score 3 + 3 ) intermediate risk prostate cancer ( Gleason score 3 + 4 ) undergo IRE treatment . These patient randomize one two group study . Group 1 : Focal ablation prostate side positive biopsy ( focal-ablation ) Group 2 : Extended ablation prostate ( extended ablation ) Patients ultrasound prostate imaging data enter Planning Software system IRE-device . The volume prostate measure specified ablation zone determine . The patient admit overnight stay hospital morning schedule IRE procedure . The IRE perform general anaesthetic specify zone identify planning stage ablate . Two four IRE electrode needle place prostate ultrasound image guidance perineal approach use brachytherapy grid . When needles place , electric pulse one two minute duration use ablate specify zone . The total procedure time approximately 1 hour . Safety data collect patient follow 1 day post-operatively , 1 month , 3 month , 6 month 1 , 2 3 year ( ) post IRE .</brief_summary>
	<brief_title>Multi-Center Randomized Clinical Trial Irreversible Electroporation Ablation Localized Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Inclusion Criteria 1 . Histologically confirm organconfined unilateral prostate cancer adjacent positive biopsy transperineal template prostate biopsy ( clinical stage T1cT2a ) . 2 . Gleason sum score 6 7 3 . PSA &lt; 15 ng/ml PSA &gt; 15 ng/mL counsel caution 4 . Life expectancy &gt; 10 year Exclusion Criteria 1 . Bleeding disorder determine prothrombin time ( PT ) &gt; 14.5 second , partial thromboplastin time ( PTT ) &gt; 34 second , Platelet Count &lt; 140/uL 2 . No ability stop anticoagulant antiplatelet therapy 7 day prior procedure . 3 . Active urinary tract infection ( UTI ) 4 . History bladder neck contracture 5 . Anaesthesia Surgical Assignment category IV great 6 . History inflammatory bowel disease 7 . Concurrent major debilitate illness 8 . Prior concurrent malignancy except basal cell carcinoma skin 9 . Cardiac history include arrhythmia , ICD pacemaker 10 . Prostate calcification great 5 mm . 11 . Biologic chemotherapy prostate cancer 12 . Hormonal therapy prostate cancer within 6 month prior procedure 13 . Previous radiation pelvis 14 . Transurethral resection prostate / Urethral stent 15 . Prior major rectal surgery ( except haemorrhoid )</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Focal therapy</keyword>
	<keyword>Irreversible electroporation</keyword>
	<keyword>Unilateral prostate cancer</keyword>
</DOC>